Linked Life Data

19057238

Source:http://linkedlifedata.com/resource/pubmed/id/19057238

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-12-5
pubmed:abstractText
The cytochrome P450 2D6 (CYP2D6) enzyme is responsible for metabolizing approximately 25% of pharmaceutical agents. Individuals with impaired CYP2D6 metabolism and those concomitantly receiving agents that inhibit CYP2D6 can have variations in concentrations of such medications and their metabolites.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1538-1145
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
368-78
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system.
pubmed:affiliation
Clinical Research Institute and University of Kansas School of Medicine, Wichita, KS 67211, USA. spreskorn@cri-research.net
pubmed:publicationType
Journal Article, Review